RESUMO
Previous studies have demonstrated that in admixed populations, West African ancestry is associated with an increased prevalence of systemic lupus erythematosus (SLE). In the current study, the effect of Amerindian ancestry in SLE was examined in an admixed population in Argentina. The Argentine population is predominantly European with approximately 20% Amerindian admixture, and a very small (<2%) contribution from West Africa. The results indicate that Amerindian admixture in this population is associated with a substantial increase in SLE susceptibility risk (Odds Ratio=7.94, P=0.00006). This difference was not due to known demographic factors, including site of collection, age and gender. In addition, there were trends towards significance for Amerindian ancestry influencing renal disease, age of onset and anti-SSA antibodies. These studies suggest that populations with Amerindian admixture, like those with West African admixture, should be considered in future studies to identify additional allelic variants that predispose to SLE.
Assuntos
Predisposição Genética para Doença , Indígenas Sul-Americanos/genética , Lúpus Eritematoso Sistêmico/genética , Algoritmos , Argentina/epidemiologia , Teorema de Bayes , Estudos de Casos e Controles , Biologia Computacional/métodos , Genética Populacional , Genótipo , Geografia , Haplótipos , Humanos , Modelos Logísticos , Razão de Chances , Polimorfismo de Nucleotídeo Único , Fatores de RiscoRESUMO
A subset of normal peripheral B lymphocytes expresses a T surface antigen recognized by monoclonal CD5. They form rosettes with mouse erythrocytes (MRBC). Other studies suggest that these B cells may have regulatory and helper properties. An expanded subset of lymphocytes forming MRBC was demonstrated in the peripheral blood of 31 Systemic Lupus Erythematosus (SLE) patients (14.4 +/- 2.8%) compared with normal controls (4.3 +/- 1.4%) and patients with tuberculosis (6.4 +/- 1.7%). Increased MRBC values correlated with disease severity. Investigation of cell surface antigen expression was attempted with enriched sedimented fractions using several monoclonal antibodies and immunofluorescent staining. Complete inhibition of MRBC formation was obtained with monoclonal antibodies against CD5, CD3 and CD8 while partial inhibition was observed with anti-Ia and no activity with CD4 and CD10 antibodies. Indirect evidence supports the concept that antilymphocyte antibodies cause T and B cell depletion and dysfunction. Sera from 12 patients with SLE and 28 with leprosy (LL) were analyzed for antibodies to lymphocytes in the microcytotoxicity assay: 87% of SLE and 57% of LL were positive. Lymphocytotoxic activity towards each cell type of a panel with 98 different HLA antigens was essentially the same and most sera were not specific for either T or B cells. Lymphocytotoxic sera from SLE and LL contained antibodies which inhibited MRBC formation.
Assuntos
Autoimunidade , Linfócitos B/fisiologia , Lúpus Eritematoso Sistêmico/imunologia , Anticorpos Monoclonais , Soro Antilinfocitário/análise , Humanos , Imunidade Celular , Contagem de Leucócitos , Formação de Roseta , Linfócitos T/fisiologiaAssuntos
Aglutininas/análise , Doença de Chagas/imunologia , Hemaglutininas/análise , Adolescente , Anticorpos/análise , Doença de Chagas/diagnóstico , Doença de Chagas/tratamento farmacológico , Criança , Pré-Escolar , Testes de Hemaglutinação , Humanos , Imunoglobulina G/análise , Imunoglobulina M/análise , Lactente , Mercaptoetanol/uso terapêutico , Trypanosoma cruzi/imunologiaAssuntos
Anticorpos Antivirais/análise , Vírus da Dengue/imunologia , Dengue/epidemiologia , Argentina , Feminino , Humanos , MasculinoRESUMO
PDCD1, an immunoreceptor involved in peripheral tolerance has previously been shown to be genetically associated with systemic lupus erythematosus (SLE). PDCD1 has two ligands whose genes are located in close proximity on chromosome 9p24. Our attention was drawn to these ligands after finding suggestive linkage to a marker (gata62f03, Z=2.27) located close to their genes in a genome scan of Icelandic families multiplex for SLE. Here, we analyse Swedish trios (N=149) for 23 single nucleotide polymorphisms (SNPs) within the genes of the PDCD1 ligands. Initially, indication of association to eight SNPs was observed, and these SNPs were therefore also analysed in Mexican trios (N=90), as well as independent sets of patients and controls from Sweden (152 patients, 448 controls) and Argentina (288 patients, 288 controls). We do not find support for genetic association to SLE. This is the first genetic study of SLE and the PDCD1 ligands and the lack of association in several cohorts implies that these genes are not major risk factors for SLE.